In a report released today, Alexei Gogolev from J.P. Morgan maintained a Buy rating on Healthequity, with a price target of $129.00. According to TipRanks, Gogolev is a 4-star analyst with an average ...
What we found: 30 stocks in the S&P 500 have implied upside of at least 30% over the next 12 months or so, according to data ...
Assimilate Live FX unifies LED wall playback, lighting control, and live compositing in one real-time platform for virtual ...
StockStory.org on MSN
Spotting winners: Veeva Systems (NYSE:VEEV) and vertical software stocks in Q3
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback